These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 124822)

  • 21. Potentiation of atracurium by pancuronium during propofol-fentanyl-N2O anesthesia.
    Nathan N; Bonada G; Feiss P
    Acta Anaesthesiol Belg; 1996; 47(4):187-93. PubMed ID: 9093646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacodynamics of neuromuscular blockade: a homogeneous phenomenon?
    Duvaldestin P
    Acta Anaesthesiol Belg; 1988; 39(3 Suppl 2):245-7. PubMed ID: 2902728
    [No Abstract]   [Full Text] [Related]  

  • 23. Dose-response relationship of rocuronium: a comparison of electromyographic vs. acceleromyographic-derived values.
    Kopman AF; Chin WA; Moe J
    Acta Anaesthesiol Scand; 2005 Mar; 49(3):323-7. PubMed ID: 15752396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical predictors of duration of action of cisatracurium and rocuronium administered long-term.
    Fassbender P; Geldner G; Blobner M; Hofmockel R; Rex C; Gautam S; Malhotra A; Eikermann M
    Am J Crit Care; 2009 Sep; 18(5):439-45. PubMed ID: 19723864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time-course of action and intubating conditions with rocuronium bromide under propofol-alfentanil anaesthesia.
    Hofmockel R; Benad G
    Eur J Anaesthesiol Suppl; 1995 Sep; 11():69-72. PubMed ID: 8557010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mechanism of action of muscle relaxants and its clinical problems].
    Suzuki H
    Masui; 1974 Aug; 23(8):679-92. PubMed ID: 4372420
    [No Abstract]   [Full Text] [Related]  

  • 27. Duration of action and hemodynamic properties of mivacurium chloride in dogs anesthetized with halothane.
    Smith LJ; Moon PF; Lukasik VM; Erb HN
    Am J Vet Res; 1999 Sep; 60(9):1047-50. PubMed ID: 10490069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The future directions in the search for postsynaptic muscle relaxants with rapidly developing and short-term action].
    Danilov AF
    Eksp Klin Farmakol; 1993; 56(4):3-6. PubMed ID: 8220010
    [No Abstract]   [Full Text] [Related]  

  • 29. Skeletal muscle relaxants: pharmacodynamics and pharmacokinetics in different patient groups.
    Booij LH; Vree TB
    Int J Clin Pract; 2000 Oct; 54(8):526-34. PubMed ID: 11198732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of time of day on the duration of neuromuscular blockade elicited by rocuronium.
    Cheeseman JF; Merry AF; Pawley MD; de Souza RL; Warman GR
    Anaesthesia; 2007 Nov; 62(11):1114-20. PubMed ID: 17924891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Posttetanic count (PTC): a new method of evaluating an intense nondepolarizing neuromuscular blockade.
    Viby-Mogensen J; Howardy-Hansen P; Chraemmer-Jørgensen B; Ording H; Engbaek J; Nielsen A
    Anesthesiology; 1981 Oct; 55(4):458-61. PubMed ID: 7294384
    [No Abstract]   [Full Text] [Related]  

  • 32. Muscle relaxants: a clinical update.
    Buzello W; Diefenbach C; Nigrovic V
    Acta Anaesthesiol Scand Suppl; 1996; 109():165-7. PubMed ID: 8901994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The inhibition of synaptic acetylcholinesterase by postsynaptic muscle relaxants].
    Danilov AF; Malygin VV
    Eksp Klin Farmakol; 1997; 60(1):25-7. PubMed ID: 9162276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of the postoperative residual curarisation using the train of four stimulation with acceleromyography.
    Fezing AK; d'Hollander A; Boogaerts JG
    Acta Anaesthesiol Belg; 1999; 50(2):83-6. PubMed ID: 10418647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Muscle relaxants in relation to intraocular tension (a clinical study).
    Khan TZ; Khan RM
    Indian J Ophthalmol; 1985; 33(3):155-62. PubMed ID: 2944825
    [No Abstract]   [Full Text] [Related]  

  • 36. [Search for new antidepolarizing muscle relaxants and the 1st experience with their clinical use].
    Vanevskiĭ VL; Danilov AF; Kotomina GL; Malygin VV; Starshinova LA
    Anesteziol Reanimatol; 1978; (4):36-8. PubMed ID: 151518
    [No Abstract]   [Full Text] [Related]  

  • 37. Rocuronium 0.3 mg x kg-1 (ED95) induces a normal peak effect but an altered time course of neuromuscular block in patients with Duchenne's muscular dystrophy.
    Muenster T; Schmidt J; Wick S; Forst J; Schmitt HJ
    Paediatr Anaesth; 2006 Aug; 16(8):840-5. PubMed ID: 16884467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative study of the dose-response and time course of recovery of atracurium and rocuronium.
    Xue F; Zhang Y; Liao X; Liu J; An G
    Chin Med J (Engl); 2000 Nov; 113(11):1019-21. PubMed ID: 11776116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the onset and intubation conditions of rocuronium bromide.
    De Mey JC; Debrock M; Rolly G
    Eur J Anaesthesiol Suppl; 1994; 9():37-40. PubMed ID: 7925206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A simple apparatus for quantitative evaluation of curarization].
    Diemunsch P; Briot D; Michel H; Dupeyron JP; Gauthier-Lafaye P
    Ann Fr Anesth Reanim; 1982; 1(6):669-70. PubMed ID: 6224445
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.